136 related articles for article (PubMed ID: 32526010)
21. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
Zeng H; Huang Y; Chen L; Li H; Ma X
Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
Liu D; Xing S; Wang W; Huang X; Lin H; Chen Y; Lan K; Chen L; Luo F; Qin S; Liang R; Bai C; Xu J; Liu W
Cancer Sci; 2020 Apr; 111(4):1093-1102. PubMed ID: 32020720
[TBL] [Abstract][Full Text] [Related]
23. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants.
de Paus RA; van de Wetering D; van Dissel JT; van de Vosse E
Mol Immunol; 2008 Sep; 45(15):3889-95. PubMed ID: 18675459
[TBL] [Abstract][Full Text] [Related]
24. Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.
Hummel TM; Ackfeld T; Schönberg M; Ciupka G; Schulz F; Oberdoerster A; Grötzinger J; Scheller J; Floss DM
Mol Cell Biol; 2017 Sep; 37(17):. PubMed ID: 28630278
[TBL] [Abstract][Full Text] [Related]
25. Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.
Lochmatter C; Fischer R; Charles PD; Yu Z; Powrie F; Kessler BM
Sci Rep; 2016 Apr; 6():24491. PubMed ID: 27080861
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients.
Zhang D; Tang D; Heng Y; Zhu XK; Zhou L; Tao L; Lu LM
Laryngoscope; 2021 Apr; 131(4):E1249-E1255. PubMed ID: 33107987
[TBL] [Abstract][Full Text] [Related]
27. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.
Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M
BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965
[TBL] [Abstract][Full Text] [Related]
28. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.
Yang J; Xu L
Med Sci Monit; 2016 Aug; 22():2785-92. PubMed ID: 27498708
[TBL] [Abstract][Full Text] [Related]
29. Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.
Xiang P; Jin S; Yang Y; Sheng J; He Q; Song Y; Yu W; Hu S; Jin J
Prostate; 2019 Jun; 79(9):1018-1031. PubMed ID: 31018021
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Takashima Y; Sakakibara-Konishi J; Hatanaka Y; Hatanaka KC; Ohhara Y; Oizumi S; Hida Y; Kaga K; Kinoshita I; Dosaka-Akita H; Matsuno Y; Nishimura M
Clin Lung Cancer; 2018 Jul; 19(4):352-359.e1. PubMed ID: 29544718
[TBL] [Abstract][Full Text] [Related]
31. Targeting STAT3 inhibition to reverse cisplatin resistance.
Sun CY; Nie J; Huang JP; Zheng GJ; Feng B
Biomed Pharmacother; 2019 Sep; 117():109135. PubMed ID: 31226634
[TBL] [Abstract][Full Text] [Related]
32. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function.
Beyranvand Nejad E; Labrie C; van der Sluis TC; van Duikeren S; Franken KLMC; Roosenhoff R; Arens R; van Hall T; van der Burg SH
Int J Cancer; 2021 Jan; 148(1):211-225. PubMed ID: 32875568
[TBL] [Abstract][Full Text] [Related]
34. Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway.
Fu Q; Liu P; Sun X; Huang S; Han F; Zhang L; Xu Y; Liu T
Cancer Cell Int; 2017; 17():79. PubMed ID: 28878571
[TBL] [Abstract][Full Text] [Related]
35. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
36. Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population.
Stevic MS; Stefanic M; Tokic S; Glavas-Obrovac L; Mihaljevic S; Karner I
Endocr Res; 2014; 39(4):164-7. PubMed ID: 24460100
[TBL] [Abstract][Full Text] [Related]
37. IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity.
Lee PW; Smith AJ; Yang Y; Selhorst AJ; Liu Y; Racke MK; Lovett-Racke AE
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878115
[TBL] [Abstract][Full Text] [Related]
38. Macrophages derived from THP-1 promote the osteogenic differentiation of mesenchymal stem cells through the IL-23/IL-23R/β-catenin pathway.
Tu B; Liu S; Liu G; Yan W; Wang Y; Li Z; Fan C
Exp Cell Res; 2015 Nov; 339(1):81-9. PubMed ID: 26477825
[TBL] [Abstract][Full Text] [Related]
39. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
40. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
